Pacira BioSciences, Inc. <PCRX.O>: Oppenheimer initiates coverage with outperform rating; price target $32
PCRX•Related News
First Breach completes first untethered flight of proprietary drone prototype
FBDT•
U.S. Research Roundup- Allstate, Autozone, Vertex Pharmaceuticals
SPY•
Levi Strauss to webcast third-quarter earnings conference call
LEVI•
Vanda Pharmaceuticals Inc <VNDA.O>: Oppenheimer initiates coverage with outperform rating; price target $10
VNDA•
PowerCompute expects hashrate to rise nearly 12% to 862 PH/s after miner refresh
PWCM•